Stevens Johnson Syndrome and Toxic Epidermal Necrolysis Reactions to BRAF and MEK Inhibitors in Patients with Melanoma: A Systematic Review

Published: 10 September 2020| Version 1 | DOI: 10.17632/zzfvyfh6pt.1
Contributor:
Muskaan Sachdeva

Description

Summary of reported Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis reactions to MAPK pathway modulators in patients with metastatic melanoma and BRAF V600 mutation.

Files

Categories

Toxic Epidermal Necrolysis

Licence